PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

LinkedIn

For FXa Inhibitor Bleeds, Fixed 2000 U and Weight-Based 50 U/kg Perform Identically

📅 Jan 1, 2025 · Journal of Pharmacy Practice
4F-PCCfactor Xa inhibitorapixabanrivaroxabanDOACreversalfixed doseweight based Anticoagulation
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

Authors: Stokes T, Johnson C, Fish T, Mishler A

Citation: Stokes T, Johnson C, Fish T, et al. Fixed vs Weight-Based Dosing of Four-Factor Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Patients With a Non-Neurologic Hemorrhage. Journal of pharmacy practice. 2025;38(6):499-506. doi:10.1177/08971900251319378

Article Links: PubMed · Journal / DOI

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Suggest a correction Request a topic
Full deep analysis for this article is still in progress. Check back soon.